Michael Forbes, CEO of Adastra, said in his initial press launch: “Damage reduction can be a critically critical and mainstream topic, and we are staying on the forefront of drug laws across the board.”We publish materials that is certainly researched, cited, edited and reviewed by licensed health-related pros. The information we provide is not